ArriVent reports phase 1 data for cancer drug ARR-217

UK’s Rayner says no Brexit reopening as Burnham floats EU free movement

Investing.com · Investing_news 48m ago

Oklo chief of staff John Hanson sells $41,129 of stock

Investing.com · News 56m ago

Emerging Debt Outruns Treasuries as Rich-World Fiscal Fears Grow

Bloomberg · Markets 57m ago

What’s Happening in EM: Bond Investors Turn to Developing World

Bloomberg · Markets 57m ago

By The Way: Headlines You May Have Missed

Bloomberg · Markets Video 1h ago

Why look at real assets into 2027?

Investing.com · News 1h ago

Dividend, stock split, resolution plans record date Oct 26: Hexaware, Midaas, Talwalkars Better Value, Ashapura Fashion

LiveMint · Markets 1h ago

Amarin’s icosapent ethyl shows survival benefit in cancer trial

Investing.com · News 1h ago

Oklo CPO Renner sells $41,129 in stock after RSU vesting

Investing.com · News 1h ago

Everpure CVO John Colgrove sells $12.46M in stock

Investing.com · News 1h ago